AUTHOR GUIDELINES

GENERAL FORMAT: Manuscript files should be prepared as follows:

  • File format: Microsoft Word document (.doc or .docx)
  • Font: Times New Roman, 12‑point
  • Layout: Single-column; 1.5 line spacing; continuous line numbering throughout the manuscript
  • Margins: 2.5 cm on all sides
  • Page numbering: Page numbers placed at the bottom (footer) of each page

LANGUAGE REQUIREMENTS: 

  • Language: English, professionally proofread by an English-language expert or professional editing service (please attach the English proofreading certificate with your submission)
  • Style: Consistent use of either American or British English throughout the manuscript (do not mix styles)

COVER LETTER: The cover letter should include:

  • A brief statement explaining the manuscript's importance and relevance to the journal's scope and readership
  • Confirmation that the manuscript has not been previously published and is not under consideration for publication elsewhere
  • A conflict-of-interest statement declaring any potential competing interests

MANUSCRIPT FILES SUBMISSION: To maintain rigorous double-blind peer review standards, authors need to prepare and submit two distinctly separate manuscript files:

  • Unblinded File: This file includes a title page detailing full author names and affiliations (consistency with ORCID records), as well as the complete contact information for the corresponding author. This document also contains the main content (refer to the Article Structure as explained below), the conflict-of-interest statement, the data availability statement, acknowledgements, funding support information, and author contributions clearly specified according to the CRediT (Contributor Roles Taxonomy).
  • Blinded File: This file does not contain author-identifying information, including names, affiliations, and any other identifying text or metadata, ensuring complete anonymity for the peer review process.

ARTICLE STRUCTURE: Submissions must adhere to the following structure. Please refer to Manuscript Template for specific formatting guidelines. 

  • Abstract: Provide a concise, self-explanatory abstract that details the introduction, objectives, methods, results, and conclusion, followed by up to five keywords. References and uncommon abbreviations should be avoided; if essential, any abbreviations must be defined at their first use within the abstract itself.
  • Introduction: Outline the study’s background and objectives clearly. Avoid detailed literature reviews or summarizing the results in this section.
  • Materials and Methods: Provide sufficient detail to ensure reproducibility, including references that support the research protocols used.
  • Results: Present findings concisely, linking them to relevant tables and figures without redundant repetition of data.
  • Discussion: Briefly explain key findings and discuss them point-by-point, contextualizing the results with supporting or contradicting references.
  • Conclusion: Summarize the main findings, emphasizing their clinical contribution.
  • Take Home Messages / Clinical Implication: Include either a short narrative message (no more than 50 words) or 3–4 concise bullet points outlining the clinical implications.
  • References: List all cited works according to the journal’s citation style.

CLINICAL TRIALS REPORTING

For all clinical trials commencing on or after June 1, 2025, prospective registration in a recognized public registry (either international or Thai registry) is strongly encouraged prior to the trial’s initiation. Authors are required to include the official trial registration number within the body of the manuscript and provide this identifier at the time of submission.

REPORTING GUIDELINES

Submitted manuscripts are strongly encouraged to adhere to the guidelines established by the Equator Network. When applicable, authors should download and complete the relevant checklist by specifying the page number where each reporting item appears in their manuscript, and submit it alongside the submission files. The recommended guidelines for specific study designs include:

  • CONSORT: For randomized controlled trials
  • STROBE: For observational studies (cohort, case-control, and cross-sectional studies)
  • PRISMA: For systematic reviews and meta-analyses
  • STARD: For diagnostic accuracy and prognostic studies
  • ARRIVE: For pre-clinical animal research
  • SCRIBE: For single-case experimental designs in behavioral intervention research

LIMITS: 

Specific limits on word count, tables, figures, and references apply according to the article type, as outlined below. Authors should ensure that their manuscripts conform to these limits prior to submission.